Reticulated Platelet Count as a Diagnostic Tool in Immune Thrombocytopenia (ITP)

Objective: This study aimed to compare the reticulated platelet count between patients having thrombocytopenia secondary to autoimmune destruction (immune thrombocytopenia {ITP}), bone marrow failure, and healthy controls who presented to a tertiary care hospital in Karachi, Pakistan.Methodology: A cross-sectional study was conducted from February 2021 to October 2022 in the Department of Hematology, National Institute of Blood Disease (NIBD) Hospital in Karachi, Pakistan, that involved examining three groups: 30 patients with immune thrombocytopenia, 30 patients with thrombocytopenia secondary to reduced production from bone marrow, and 30 healthy controls.The study utilized the Sysmex XN-1000 (Hyogo, Japan: Sysmex Corporation) automated hematology analyzer to perform a complete blood count (CBC) test.Additionally, peripheral blood was stained with Leishman stain and examined under a microscope to eliminate pseudo thrombocytopenia and identify any abnormal cells or dysplasia.The immature platelet fraction (IPF) was then performed on Sysmex XN 1000 after ensuring adequate quality control.Finally, the data were analyzed using DATAtab (Graz, Austria: DATAtab) and SPSS version 25 (Armonk, NY: IBM Corp.).Results: Of the ninety participants, the median age was 33 years with a range of 18-71 years.Patients with ITP had a significantly higher median IPF% (median=26.65,IQR=15-39.4)than thrombocytopenia due to bone marrow failure (median=9.25,IQR=4.55-14.30)and healthy controls (median=7, IQR=4.40-9.90),with a p-value of 0.001.The immune thrombocytopenia group demonstrated an increase in IPF% as platelet counts increased, indicating a significant moderate correlation between IPF% and platelets in these patients (r=0.438,p=0.016) and confirming that IPF% was an independent predictor for the detection of ITP.Conclusion: Reticulated platelet count may be a useful diagnostic tool to differentiate between ITP and thrombocytopenia caused by bone marrow failure.Because of its non-invasive nature, IPF is a valuable tool for expediting the management of thrombocytopenia associated with increased IPF.